Home > Journals > Minerva Chirurgica > Past Issues > Minerva Chirurgica 2015 April;70(2) > Minerva Chirurgica 2015 April;70(2):141-5

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

MINERVA CHIRURGICA

A Journal on Surgery


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,115


eTOC

 

REVIEWS  


Minerva Chirurgica 2015 April;70(2):141-5

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Surgical management of anal cancer

Gilshtein H., Khoury W.

Department of General Surgery, Rambam Health Care Campus, Haifa, Israel


PDF  


Squamous cell carcinoma (SCC) is the most common malignancy of the anal canal and anal region. The prevalence of transformation to SCC is much higher in patients with a concomitant human immundefficiency virus (HIV) infection. Historically, treatment of anal SCC consisted of surgical resection with wide local excision for small sized tumors and abdominoperineal resection (APR) for larger and locally invasive cancer. The introduction of chemoradiation by Nigro et al. revolutionized the treatment of SCC. It has improved local recurrence rates as well as survival and need for colostomy. Nowadays, primary surgical treatment is indicated for anal margin tumors that are smaller than 2 cm, and are not poorly differentiated. However, extensive surgery is reserved for those with persistent, progressing and recurrent disease after treatment with the Nigro protocol. Surgical approach for anal canal and margin cancer is to be discussed in this review.

top of page

Publication History

Cite this article as

Gilshtein H, Khoury W. Surgical management of anal cancer. Minerva Chir 2015 April;70(2):141-5. 

Corresponding author e-mail

wekhoury@gmail.com